dynavax.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Dynavax Technologies | Toll-like Receptor | |
| Description | Make A Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 69.63.140.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
dynavax.com Valuation
|
US$51,042,636
Last updated: 2023-04-27 19:15:41
dynavax.com has Semrush global rank of 207,362. dynavax.com has an estimated worth of US$ 51,042,636, based on its estimated Ads revenue. dynavax.com receives approximately 5,889,535 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, dynavax.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$51,042,636 |
| Daily Ads Revenue | US$47,117 |
| Monthly Ads Revenue | US$1,413,489 |
| Yearly Ads Revenue | US$16,961,861 |
| Daily Unique Visitors | 392,636 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| dynavax.com. | A | 1800 | IP: 69.63.140.80 |
| dynavax.com. | NS | 86400 | NS Record: ns-605.awsdns-11.net. |
| dynavax.com. | NS | 86400 | NS Record: ns-1111.awsdns-10.org. |
| dynavax.com. | NS | 86400 | NS Record: ns-1605.awsdns-08.co.uk. |
| dynavax.com. | NS | 86400 | NS Record: ns-444.awsdns-55.com. |
| dynavax.com. | MX | 7200 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
| dynavax.com. | MX | 7200 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
| dynavax.com. | TXT | 300 | TXT Record: atlassian-domain-verification=m7jftEQPwHPpFd7fBBdSUpyKDGEoEEhPd4EPahTTBveEuYXoaiNmVQlMAaYN76OE |
| dynavax.com. | TXT | 300 | TXT Record: bpu40vriorpqqb768v6tc4urbc |
| dynavax.com. | TXT | 300 | TXT Record: o4btfil8bsf9pruv6dd3v297di |
| dynavax.com. | TXT | 300 | TXT Record: v=spf1 include:_netblocks.mimecast.com include:spf.protection.outlook.com include:mail.zendesk.com ip4:23.253.155.200 ip4:50.230.51.243 ~all |
| dynavax.com. | TXT | 300 | TXT Record: MS=ms76427986 |
| dynavax.com. | TXT | 300 | TXT Record: UPMzckGNM9xp3ZCSh7tpmwSogo3js4k7CZH0yvvwU7u+2L3SKoKL/p8hJOCHgOS+k74s69HgFE5k4e2WdgSxPg== |
HtmlToTextCheckTime:2023-04-27 19:15:41
| About Overview Management Board of Directors Dynavax Europe Product HEPLISAV-B ® Science Overview Publications & Presentations CpG 1018 ® Pipeline Clinical Trials Investors Overview Press Releases Events & Presentations Stock Information Analyst Coverage Financials SEC Filings Annuals and Proxies Corporate Governance and Compliance Board of Directors Committee Composition Contact the Board Contact Us Careers Join Our Team Values Job Opportunities Benefits Contact --> --> Preventing infectious diseases with proven adjuvant technology Committed to developing novel vaccines We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology. who we are Make A Difference Join a dynamic team dedicated to making a difference Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 01:18:59 GMT Server: Apache Location: https://www.dynavax.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 21 Oct 2021 01:19:00 GMT Server: Apache Vary: User-Agent,Accept-Encoding ETag: 432gc3 Cache-Control: max-age=30, s-maxage=30 Expires: Thu, 21 Oct 2021 01:19:30 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Content-Security-Policy-Report-Only: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self' https://dynavax.sharepoint.com; frame-src 'self' player.vimeo.com *.youtube.com www.google.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com www.googletagmanager.com maps.googleapis.com; img-src 'self' data: www.google-analytics.com maps.googleapis.com maps.gstatic.com www.googletagmanager.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
dynavax.com Whois Information
Domain Name: DYNAVAX.COM Registry Domain ID: 578866_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-01T13:51:03Z Creation Date: 1997-02-07T05:00:00Z Registry Expiry Date: 2027-02-08T05:00:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1111.AWSDNS-10.ORG Name Server: NS-1605.AWSDNS-08.CO.UK Name Server: NS-444.AWSDNS-55.COM Name Server: NS-605.AWSDNS-11.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T17:51:54Z <<< |